Page last updated: 2024-10-27

flumazenil and Protein Aggregation, Pathological

flumazenil has been researched along with Protein Aggregation, Pathological in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papadimas, GK1
Evilä, A1
Papadopoulos, C1
Kararizou, E1
Manta, P1
Udd, B1

Other Studies

1 other study available for flumazenil and Protein Aggregation, Pathological

ArticleYear
GNE-Myopathy in a Greek Romani Family with Unusual Calf Phenotype and Protein Aggregation Pathology.
    Journal of neuromuscular diseases, 2016, 05-27, Volume: 3, Issue:2

    Topics: Adult; DNA-Binding Proteins; Greece; Homozygote; Humans; Leg; Male; Microtubule-Associated Proteins;

2016